The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 23, 2026 | Agarwal Sunil | Director | Disposed to issuer(D) | 27K | — | — |
| Jan 23, 2026 | Agarwal Sunil | Director | Disposed to issuer(D) | 28K | — | — |
| Jan 23, 2026 | Bate Kenneth | Director | Disposed to issuer(D) | 8K | — | — |
| Jan 23, 2026 | Bate Kenneth | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Bate Kenneth | Director | Disposed to issuer(D) | 17K | — | — |
| Jan 23, 2026 | Bate Kenneth | Director | Disposed to issuer(D) | 27K | — | — |
| Jan 23, 2026 | Bate Kenneth | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Beck Joanne T. | Director | Disposed to issuer(D) | 17K | — | — |
| Jan 23, 2026 | Beck Joanne T. | Director | Disposed to issuer(D) | 8K | — | — |
| Jan 23, 2026 | Beck Joanne T. | Director | Disposed to issuer(D) | 27K | — | — |
| Jan 23, 2026 | Beck Joanne T. | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Beck Joanne T. | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Callori Fred | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Callori Fred | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Callori Fred | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Callori Fred | Director | Disposed to issuer(D) | 8K | — | — |
| Jan 23, 2026 | Callori Fred | Director | Disposed to issuer(D) | 27K | — | — |
| Jan 23, 2026 | Clauser Noah | Chief Financial Officer | Disposed to issuer(D) | 263K | — | — |
| Jan 23, 2026 | Clauser Noah | Chief Financial Officer | Disposed to issuer(D) | 55K | — | — |
| Jan 23, 2026 | Cole Hugh M | Director | Disposed to issuer(D) | 8K | — | — |
| Jan 23, 2026 | Cole Hugh M | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Cole Hugh M | Director | Disposed to issuer(D) | 27K | — | — |
| Jan 23, 2026 | Cole Hugh M | Director | Disposed to issuer(D) | 17K | — | — |
| Jan 23, 2026 | Cole Hugh M | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Harshbarger Benjamin | Chief Legal Officer | Disposed to issuer(D) | 33K | — | — |
| Jan 23, 2026 | Harshbarger Benjamin | Chief Legal Officer | Disposed to issuer(D) | 263K | — | — |
| Jan 23, 2026 | Harshbarger Benjamin | Chief Legal Officer | Disposed to issuer(D) | 55K | — | — |
| Jan 23, 2026 | Kishbauch Michael D | Director | Disposed to issuer(D) | 8K | — | — |
| Jan 23, 2026 | Kishbauch Michael D | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Kishbauch Michael D | Director | Disposed to issuer(D) | 27K | — | — |
| Jan 23, 2026 | Kishbauch Michael D | Director | Disposed to issuer(D) | 17K | — | — |
| Jan 23, 2026 | Kishbauch Michael D | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Komjathy Andrew | Chief Commercial Officer | Disposed to issuer(D) | 10 | — | — |
| Jan 23, 2026 | Komjathy Andrew | Chief Commercial Officer | Disposed to issuer(D) | 45 | — | — |
| Jan 23, 2026 | Komjathy Andrew | Chief Commercial Officer | Disposed to issuer(D) | 45 | — | — |
| Jan 23, 2026 | Komjathy Andrew | Chief Commercial Officer | Disposed to issuer(D) | 225K | — | — |
| Jan 23, 2026 | Komjathy Andrew | Chief Commercial Officer | Disposed to issuer(D) | 55K | — | — |
| Jan 23, 2026 | Lapointe Anthony Gregg | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Lapointe Anthony Gregg | Director | Disposed to issuer(D) | 27K | — | — |
| Jan 23, 2026 | Lapointe Anthony Gregg | Director | Disposed to issuer(D) | 8K | — | — |
| Jan 23, 2026 | Lapointe Anthony Gregg | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Lapointe Anthony Gregg | Director | Disposed to issuer(D) | 17K | — | — |
| Jan 23, 2026 | Matthews Andrea | Chief Business Officer | Disposed to issuer(D) | 263K | — | — |
| Jan 23, 2026 | Matthews Andrea | Chief Business Officer | Disposed to issuer(D) | 20K | — | — |
| Jan 23, 2026 | Matthews Andrea | Chief Business Officer | Disposed to issuer(D) | 33K | — | — |
| Jan 23, 2026 | Milne Jill C. | CEO and President, Director | Disposed to issuer(D) | 4K | — | — |
| Jan 23, 2026 | Milne Jill C. | CEO and President, Director | Disposed to issuer(D) | 761K | — | — |
| Jan 23, 2026 | Milne Jill C. | CEO and President, Director | Disposed to issuer(D) | 195K | — | — |
| Jan 23, 2026 | Morabito Christopher | Chief Medical Officer | Disposed to issuer(D) | 263K | — | — |
| Jan 23, 2026 | Morabito Christopher | Chief Medical Officer | Disposed to issuer(D) | 80K | — | — |
| Jan 23, 2026 | Violin Jonathan | Director | Disposed to issuer(D) | 263K | — | — |
| Jan 23, 2026 | Violin Jonathan | Director | Disposed to issuer(D) | 8K | — | — |
| Jan 23, 2026 | Violin Jonathan | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Violin Jonathan | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Violin Jonathan | Director | Disposed to issuer(D) | 14K | — | — |
| Jan 23, 2026 | Violin Jonathan | Director | Disposed to issuer(D) | 27K | — | — |
| Jun 11, 2025 | Callori Fred | Director | Grant(A) | 27K | — | $0 |
| Jun 11, 2025 | Beck Joanne T. | Director | Grant(A) | 27K | — | $0 |
| Jun 11, 2025 | Violin Jonathan | Director | Grant(A) | 27K | — | $0 |
| Jun 11, 2025 | Lapointe Anthony Gregg | Director | Grant(A) | 27K | — | $0 |
| Jun 11, 2025 | Kishbauch Michael D | Director | Grant(A) | 27K | — | $0 |
| Jun 11, 2025 | Cole Hugh M | Director | Grant(A) | 27K | — | $0 |
| Jun 11, 2025 | Bate Kenneth | Director | Grant(A) | 27K | — | $0 |
| Jun 11, 2025 | Agarwal Sunil | Director | Grant(A) | 27K | — | $0 |
| Mar 21, 2025 | Morabito Christopher | Chief Medical Officer | Grant(A) | 263K | — | $0 |
| Mar 21, 2025 | Clauser Noah | Chief Financial Officer | Grant(A) | 263K | — | $0 |
| Mar 21, 2025 | Harshbarger Benjamin | Chief Legal Officer | Grant(A) | 263K | — | $0 |
| Mar 21, 2025 | Komjathy Andrew | Chief Commercial Officer | Grant(A) | 225K | — | $0 |
| Mar 21, 2025 | Matthews Andrea | Chief Business Officer | Grant(A) | 263K | — | $0 |
| Mar 21, 2025 | Milne Jill C. | CEO and President, Director | Grant(A) | 761K | — | $0 |
| Jun 5, 2024 | Bate Kenneth | Director | Grant(A) | 14K | — | $0 |
| Jun 5, 2024 | Cole Hugh M | Director | Grant(A) | 14K | — | $0 |
| Jun 5, 2024 | Kishbauch Michael D | Director | Grant(A) | 14K | — | $0 |
| Jun 5, 2024 | Callori Fred | Director | Grant(A) | 14K | — | $0 |
| Jun 5, 2024 | Violin Jonathan | Director | Grant(A) | 14K | — | $0 |
| Jun 5, 2024 | Beck Joanne T. | Director | Grant(A) | 14K | — | $0 |
| Jun 5, 2024 | Lapointe Anthony Gregg | Director | Grant(A) | 14K | — | $0 |
| Apr 8, 2024 | Agarwal Sunil | Director | Grant(A) | 28K | — | $0 |
| Apr 1, 2024 | Morabito Christopher | Chief Medical Officer | Option exercise(M) | 10K | $3.87 | $39K |
| Apr 1, 2024 | Morabito Christopher | Chief Medical Officer | Sell(S) | 10K | $13.59 | $136K |
| Apr 1, 2024 | Morabito Christopher | Chief Medical Officer | Option exercise(M) | 10K | — | $0 |
| Feb 8, 2024 | Clauser Noah | Chief Financial Officer | Grant(A) | 175K | — | $0 |
| Feb 8, 2024 | Harshbarger Benjamin | Chief Legal Officer | Grant(A) | 175K | — | $0 |
| Feb 8, 2024 | Komjathy Andrew | Chief Commercial Officer | Grant(A) | 175K | — | $0 |
| Feb 8, 2024 | Matthews Andrea | Chief Business Officer | Grant(A) | 175K | — | $0 |
| Feb 8, 2024 | Milne Jill C. | CEO and President, Director | Grant(A) | 535K | — | $0 |
| Feb 8, 2024 | Morabito Christopher | Chief Medical Officer | Grant(A) | 175K | — | $0 |
| Feb 1, 2024 | Perceptive Xontogeny Venture Fund, LP | Director | Buy(P) | 2.5M | $12.09 | $30.0M |
| Jan 29, 2024 | Morabito Christopher | Chief Medical Officer | Sell(S) | 9K | $11.15 | $103K |
| Jan 29, 2024 | Morabito Christopher | Chief Medical Officer | Option exercise(M) | 9K | $3.87 | $36K |
| Jan 29, 2024 | Morabito Christopher | Chief Medical Officer | Option exercise(M) | 9K | — | $0 |
| Jan 26, 2024 | Morabito Christopher | Chief Medical Officer | Option exercise(M) | 800 | $3.87 | $3K |
| Jan 26, 2024 | Morabito Christopher | Chief Medical Officer | Sell(S) | 800 | $11.02 | $9K |
| Jan 26, 2024 | Morabito Christopher | Chief Medical Officer | Option exercise(M) | 800 | — | $0 |
| Dec 21, 2023 | Perceptive Advisors LLC | Director | Buy(P) | 740K | $6.20 | $4.6M |
| Oct 16, 2023 | Perceptive Life Sciences Master Fund Ltd | Director | Buy(P) | 614K | $6.51 | $4.0M |
| Oct 16, 2023 | Perceptive Life Sciences Master Fund Ltd | Director | Buy(P) | 461K | $6.51 | $3.0M |
| Oct 16, 2023 | Perceptive Life Sciences Master Fund Ltd | Director | Buy(P) | 461K | $6.51 | $3.0M |
| Oct 16, 2023 | Perceptive Life Sciences Master Fund Ltd | Director | Buy(P) | 921K | $6.51 | $6.0M |
| Oct 16, 2023 | Perceptive Life Sciences Master Fund Ltd | Director | Buy(P) | 921K | $6.51 | $6.0M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).